HIV status does not affect liver transplant outcomes, 15-year Spanish study finds
23% of people with HIV in the UK have depression or anxiety, but rates are much higher in some groups
Once-weekly combination of islatravir and lenacapavir safe and effective in 48-week study
Much lower HIV knowledge and access to testing for people with disabilities globally
Uganda achieves rapid scale-up of cervical screening for women living with HIV
Dolutegravir resistance very rare after a switch - even with detectable HIV
Most people on dolutegravir resuppress viral load after a detectable result
Lamivudine resistance mutation may persist for many years in some people with HIV
Thank you and farewell
